Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide

被引:0
|
作者
Penina Tarshish
Jay Bernstein
Chester M. Edelmann
机构
[1] Albert Einstein College of Medicine,Department of Anatomic Pathology
[2] William Beaumont Hospital,Room 803
[3] Jacobi Medical Center,undefined
来源
Pediatric Nephrology | 2004年 / 19卷
关键词
Purpura; Henoch-Schönlein; Cyclophosphamide; Nephritis; Natural history; Pediatrics; Clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
Nephritis in Henoch-Schönlein purpura (HSP) is the primary cause of morbidity and mortality. Although many therapeutic regimens have been reported to be effective, no therapy has been shown in a controlled trial to be beneficial. Fifty-six patients with histopathologically severe HSP nephritis were randomized to receive supportive therapy with or without cyclophosphamide, 90 mg/m2/day for 42 days. Patients were classified according to status at final follow-up: Fully Recovered 48.2%, Persistent Abnormalities 39.3%, or ESRD/Death 12.5%. There were no differences in onset data or outcome between the two trial groups or in outcome between trial and 23 non-trial patients followed concurrently. Therefore, data from trial and non-trial patients were combined for further analysis. There was no correlation between outcome and age, blood pressure, serum total protein, or serum albumin. Although rates of proteinuria did not correlate with outcome, all those with progression to ESRD had nephrotic levels of proteinuria at onset. Only five of 28 patients with nephrotic levels of proteinuria and severe onset histopathology recovered fully. No patient with crescents in 50% or more of glomeruli went on to full recovery. Recurrence of non-renal symptoms did not correlate with outcome. Nephrotic syndrome, decreased GFR, and more severe histopathology at onset, as well as persistence of urinary abnormalities for several years, are ominous signs.
引用
收藏
页码:51 / 56
页数:5
相关论文
共 50 条
  • [41] Molecular Targets and Mechanisms of Poria cocos-Licorice Drug Pair for the Treatment of Henoch-Schönlein Purpura Nephritis Based on Network Pharmacology
    Liu, Jiahua
    Liu, Qingqing
    Ma, Xiaoqin
    Guo, Weiyan
    Mi, Jie
    PHARMACOGNOSY MAGAZINE, 2024, 20 (04) : 1167 - 1178
  • [42] Necrosis of mesenteric lymph nodes in Henoch–Schönlein purpura
    Pietro Ferrara
    Donato Rigante
    Antonio Leone
    Claudia Orchi
    Nadia Puma
    Aurora Rossodivita
    Emanuela Sacco
    Pio Liberatore
    Maria Elena Laino
    Achille Stabile
    Rheumatology International, 2012, 32 : 563 - 564
  • [43] Hemorrhagic Bullous Lesions in a Girl with Henoch Schönlein Purpura
    Sonia Mehra
    Deepti Suri
    Sunil Dogra
    Anju Gupta
    Amit Rawat
    Biman Saikia
    Ranjana W. Minz
    Ritambhara Nada
    Surjit Singh
    The Indian Journal of Pediatrics, 2014, 81 : 210 - 211
  • [44] Clinical practice:Diagnosis and management of Henoch–Schönlein purpura
    Hugh J. McCarthy
    E. Jane Tizard
    European Journal of Pediatrics, 2010, 169 : 643 - 650
  • [45] Henoch–Schönlein nephritis with nephrotic state in children: predictors of poor outcomes
    Hitoshi Wakaki
    Kenji Ishikura
    Pediatric Nephrology, 2012, 27 : 335 - 335
  • [46] Correlation between antiphospholipid antibodies and renal involvement in children with Henoch-Schönlein purpura: A cross-sectional study
    Yeganeh, Mehrnoush Hassas
    Sinaei, Reza
    Yaraghi, Aye
    Rahmani, Khosro
    Parvaneh, Vadood Javadi
    Shiari, Reza
    Hosseinzadeh, Hamid
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2024, 15 (02) : 287 - 293
  • [47] Blistering eruptions in childhood Henoch-Schönlein syndrome: systematic review of the literature
    Vera Ramelli
    Sebastiano A. G. Lava
    Giacomo D. Simonetti
    Mario G. Bianchetti
    Gian Paolo Ramelli
    Gregorio P. Milani
    European Journal of Pediatrics, 2017, 176 : 487 - 492
  • [48] Schönlein-Henoch Purpura in Children and AdultsDiagnosis, Pathophysiology and Management
    Guy Rostoker
    BioDrugs, 2001, 15 : 99 - 138
  • [49] Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch–Schönlein purpura
    Yilmaz Tabel
    Sevgi Mir
    Afig Berdeli
    Rheumatology International, 2012, 32 : 941 - 947
  • [50] Initial manifestations and short term follow-up results of Henoch-Schönlein purpura in children: A report from two centers
    Ozturk, Kubra
    Cakan, Mustafa
    NORTHERN CLINICS OF ISTANBUL, 2020, 7 (04) : 341 - 347